U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
119011119011Metabolic Syndrome and Fingertip Endothelial DysfunctionCompletedNo Results AvailableMetabolic SyndromeOther: Lifestyle instructionhttps://ClinicalTrials.gov/show/NCT01007227
119012119012Guided Biopsy for Mapping Prostate CancerTerminatedNo Results AvailableProstate CancerProcedure: Prostatectomyhttps://ClinicalTrials.gov/show/NCT01007214
119013119013Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric PopulationCompletedNo Results AvailableInfluenzaBiological: Influenza A (H1N1) 2009 monovalent vaccine, inactivatedhttps://ClinicalTrials.gov/show/NCT01007201
119014119014Energy Value of Macronutrients From Almonds and Mechanisms of Nutrient ActionCompletedNo Results AvailableHealthyOther: 1.5PD almonds|Other: 3.0PD almonds|Other: Base (without almonds)https://ClinicalTrials.gov/show/NCT01007188
119015119015Study Evaluating Multiple Ascending Doses Of ATN-103 In Japanese Subjects With Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisBiological: ATN-103 10 mg q4wks|Biological: ATN-103 30 mg q4wks|Biological: ATN-103 80 mg q4wks|Biological: ATN-103 10 mg q8wks|Biological: ATN-103 80 mg q8wkshttps://ClinicalTrials.gov/show/NCT01007175
119016119016Patient Satisfaction in the Critical Care Unit: A Qualitative Phenomenological StudyRecruitingNo Results AvailablePatient Satisfaction in the Critical Care Unithttps://ClinicalTrials.gov/show/NCT01007162
119017119017Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled AsthmaCompletedHas ResultsAsthmaDrug: omalizumab|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01007149
119018119018Transcranial Direct Current Stimulation (tDCS)-Enhanced Stroke RecoveryCompletedNo Results AvailableIschemic StrokeDevice: tDCS|Device: Sham tDCShttps://ClinicalTrials.gov/show/NCT01007136
119019119019Study of A3309 in Patients With Chronic Idiopathic ConstipationCompletedNo Results AvailableConstipation|Chronic ConstipationDrug: A3309https://ClinicalTrials.gov/show/NCT01007123
119020119020Effects of Docosahexaenoic Acid (DHA) on Fetal Cardiac OutcomesCompletedHas ResultsPregnancyDietary Supplement: DHA|Other: Placebohttps://ClinicalTrials.gov/show/NCT01007110
119021119021Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes MellitusCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: TAK-875|Drug: TAK-875|Drug: TAK-875|Drug: TAK-875|Drug: TAK-875|Drug: Glimepiride|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01007097
119022119022TRAUMA HELP: Healing and Analgesia With PropranololWithdrawnNo Results AvailableTraumaDrug: Propranolol|Drug: Propranolol ER|Drug: Sugar pillshttps://ClinicalTrials.gov/show/NCT01007084
119023119023Effects of Growth Hormone on Cognition and Cerebral Metabolism in AdultsRecruitingNo Results AvailableHypopituitarismDrug: Human Growth hormone - nutropinhttps://ClinicalTrials.gov/show/NCT01007071
119024119024Markers of Response to Intravesical Bladder Cancer TherapyActive, not recruitingNo Results AvailableBladder Cancerhttps://ClinicalTrials.gov/show/NCT01007058
119025119025Limited Compression Ultrasound by Emergency Physicians to Exclude Deep Vein ThrombosisCompletedNo Results AvailableDeep Vein Thrombosishttps://ClinicalTrials.gov/show/NCT01007045
119026119026A Study of IMC-A12 in Advanced Solid TumorsCompletedNo Results AvailableTumorsBiological: IMC-A12https://ClinicalTrials.gov/show/NCT01007032
119027119027Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH4808 After Oral Administration in Healthy Male SubjectsCompletedNo Results AvailableHealthyDrug: YH4808 30mg|Drug: YH4808 50mg|Drug: YH4808 100mg|Drug: YH4808 200mg|Drug: YH4808|Drug: YH4808 100mg (repeat dose)|Drug: YH4808 200mg (repeat dose)|Drug: YH4808 600mg|Drug: YH4808 800mg (single dose)|Drug: YH4808 400 mg (repeat doses)|Drug: Placebo|Drug: Esomeprazole 40mghttps://ClinicalTrials.gov/show/NCT01007019
119028119028Telepharmacy Robotic Medicine Delivery Unit "TRMDU" AssessmentNot yet recruitingNo Results AvailableTraumatic Brain Injury|Posttraumatic Stress Disorders|Trauma|Combat Disorders|PainDevice: TMRDUhttps://ClinicalTrials.gov/show/NCT01007006
119029119029Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen ActivatorCompletedNo Results AvailableIschemic StrokeDevice: NeuroFlo catheterhttps://ClinicalTrials.gov/show/NCT01006993
119030119030A Study of RO5185426 in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3)Active, not recruitingHas ResultsMalignant MelanomaDrug: RO5185426|Drug: dacarbazinehttps://ClinicalTrials.gov/show/NCT01006980
119031119031ActiveStep Comparative Effectiveness TrialActive, not recruitingNo Results AvailableGait InstabilityDevice: ActiveStep Treadmill|Other: Physical Therapyhttps://ClinicalTrials.gov/show/NCT01006967
119032119032Outcome of Two Protocols in Poor Responders in Assisted Reproductive Technology (ART) CycleCompletedNo Results AvailableInfertilityDrug: Microdose GnRh|Drug: Flare uphttps://ClinicalTrials.gov/show/NCT01006954
119033119033Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety StudyCompletedNo Results AvailableRelapsing Multiple SclerosisBiological: Trichuris suis ovahttps://ClinicalTrials.gov/show/NCT01006941
119034119034Association Between the Support of NICU Team and Subjective Health of ParentsCompletedNo Results AvailableConditions Influencing Health StatusOther: Questionairehttps://ClinicalTrials.gov/show/NCT01006928
119035119035Surgical Decompression for Diabetic Neuropathy in the FootRecruitingNo Results AvailableDiabetic PolyneuropathyProcedure: Surgeryhttps://ClinicalTrials.gov/show/NCT01006915
119036119036Outcomes of Oncology Therapy in the Elderly: Trajectory of Functional Decline and Correlates of ChangeTerminatedNo Results AvailableCancerhttps://ClinicalTrials.gov/show/NCT01006902
119037119037Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver DiseaseCompletedNo Results AvailableNonalcoholic Fatty Liver Disease|Type 2 Diabetes MellitusDrug: Exenatidehttps://ClinicalTrials.gov/show/NCT01006889
119038119038Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter AblationCompletedNo Results AvailableThromboembolismDrug: Coumadin|Drug: Coumadin|Drug: Coumadinhttps://ClinicalTrials.gov/show/NCT01006876
119039119039Preoperative Ephedrine Attenuates the Hemodynamic Responses of Propofol During Valve Surgery: A Dose Dependent StudyCompletedNo Results AvailableHypotension|Valve SurgeryDrug: Ephedrine|Drug: Placebo|Drug: Phenylephrinehttps://ClinicalTrials.gov/show/NCT01006863
119040119040Fixed Dose of Intravenous Hydromorphone in the Treatment of Acute PainCompletedNo Results AvailableAcute PainDrug: Hydromorphonehttps://ClinicalTrials.gov/show/NCT01006850

* Görseller ve İçerik tekif hakkına sahip olabilir